Clinical Trial Participation Participating in clinical trials can sometimes provide access to GLP-1 medications at no cost
General Wound Healing and Tissue Repair Beyond tendons, BPC-157 has been studied in models of skin wound healing, bone repair, corneal injury, and muscle damage
30 mg vial reconstitution chart For the 30 mg vial, the 10 mg/mL concentration (3.0 mL water) is the gold standard
GLP-1 medications may cause gastrointestinal side effects like nausea or constipation as your body adjusts, while berberine typically causes minimal side effects
Most common side effects were gastrointestinal, with 24.5% of participants in the phase 2 obesity trial discontinuing efinopegdutide 10 mg due to AE however when the same dose was used with gradual escalation at the MASLD trial (starting dose 2.4 mg for 4 weeks, then 5 mg for 4 weeks and then 10 mg), only 5.6% of participants discontinued the medication due to AE
This should not be required unless you have used up nearly all of the product
